Patient, care partner, and provider voice in treatment decision-making for non-small cell lung cancer
Our study reinforces the relevance of SDM in NSCLC; however, some patients who wish for greater involvement in decisions may find their preferences overlooked.
Authors
- Josh Feldman (ORCID: https://orcid.org/0009-0005-1751-4459)
- Jhanelle E. Gray (ORCID: https://orcid.org/0000-0003-1304-7062)
- Pratyusha Vadagam
- Blanca Ledezma
- M Yung (ORCID: https://orcid.org/0009-0001-2967-6851)
- Victoria Kulbokas (ORCID: https://orcid.org/0000-0001-6787-6339)
- Kathleen L. Deering
- Julie Vanderpoel (ORCID: https://orcid.org/0000-0001-5055-6216)
- Mansi Patel (ORCID: https://orcid.org/0000-0002-7917-8666)
- Upal Roy (ORCID: https://orcid.org/0000-0002-0325-567X)
- Lisa Dwyer Orr
Institutions
- Johnson & Johnson (United States) (US)
- University of California, Los Angeles (US)
- Moffitt Cancer Center (US)
- University of Santa Monica (US)
- LUNGevity Foundation (US)
- Epi-Q (United States) (US)
- Inspire Institute (US)
- Stanford University (US)
Publication Details
- Journal
- Patient Education and Counseling
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1016/j.pec.2025.108776
- Citations
- 2
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Johnson and Johnson